NutraFuels (NTFU): Soaring Revenue & Narrowing Losses
December 12th, 2016
News, Top News
The global market for nutraceuticals is expected to eclipse $240 billion by 2019, according to BCC Research, driven by increasing health concerns, growing government support, aging populations, and advancing per capita incomes. Nutraceutical International Corp. (NASDAQ: NUTR) and other large manufacturers, marketers, and distributors have grown tremendously, but smaller companies could provide investors with the greatest upside potential.
NutraFuels Inc. (OTC Pink: NTFU) is a manufacturer, marketer, and distributor of liquid-based nutraceuticals delivered via oral sprays and drink shots. With a superior absorption rate compared to traditional nutraceuticals (e.g. pills), the company’s seven product lines have seen tremendous sales growth over the past few quarters. The company has also begun the launch of new hemp-based cannabidiol (CBD) product to participate in the booming cannabis industry.
In this article, we will look at the company’s innovative technology, growing product lines, and how they could unlock significant shareholder value.
Innovative Delivery Systems
NutraFuels sets itself apart from the competition with its innovative delivery mechanisms for nutraceutical products. With up to a 98% absorption rate, the company’s oral sprays products allow for optimal delivery of vitamins and nutrients in to the human body. This oral delivery system has been proven to be more efficient and effective than other traditional methods such as pills, powders, and other delivery mechanisms that rely on metabolism in the gut.
The company currently has three core in-house products on the market targeting sleep (Sleep Support), appetite control (Weight Loss), and hair, skin, and nail health (Spa Treatment) that are being sold on www.shopnutraspray.com and on Amazon.com. The company’s private-label partners include My Daily Choice, NutraXt, and Journey Health USA, which sell customized products through their networks to thousands of individuals worldwide.
In addition to these products, the company has developed several new oral spray products containing industrial hemp CBD-rich oils supporting pain relief, sleep, anti-stress/relaxation, energy & focus, and daily wellness. The company has also developed and is producing private-labeled hemp-based CBD products including; oral sprays, tinctures and drink shots for partner and private label customer Hempgenix, targeting the same health and wellness indications. With the rapid growth of the CBD industry, the company could see significant revenue acceleration from the distribution and sales of new products being sold to the mass markets.
Improving Financial Condition
NutraFuels recently announced third quarter revenue that increased 111.2% to $260,001, gross margins that increased 769% to $153,000, and a net loss that narrowed 51% to $657,000 or $0.02 per share. Management completed a series of production runs for both house and private label brands and is focused on marketing and distributing the products to customers around the world as it enters its commercialization phase.
In late-October, the company announced that it had begun production on 100,000 units for one of its private label brands, My Daily Choice, consisting of six oral spray products targeting various wellness verticals. My Daily Choice has approximately 50,000 distributors worldwide consisting of some of the most successful entrepreneurs, marketers, and consultants in the network marketing sector, making them a natural choice for distribution.
“We have made progress this quarter,” said Edgar Ward, Nutrafuels’s CEO. “We are strategically executing our game plan, and we are seeing a positive reaction to the launch of our in house brands along with increased production demand from our private label business. As we move forward with additional new innovative formulas and products we remain focused on producing and distributing high quality daily health and wellness products to help improve the quality of life through naturally derived efficient and effective supplementation.”
NutraFuels operates in a large and growing industry with tremendous room for upside. With a unique delivery mechanism, the company’s rapidly expanding product lines are quickly gaining traction in terms of revenue. Management also remains focused on narrowing its losses and achieving profitability over the long-run. Investors should take note of these trends as the company looks to up-list or become a potential acquisition target.
For more information, visit the company’s website at www.nutrafuels.com.
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.